...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: Buyers need sellers....why I think delivery failures are important

Growacet, agree with you, the float is so small, most of us are long term, volume so low and spread too great to sell short and recover.  Believe you are right, next five days many shares will be covered.  Exciting week, Wednesday FDA, Saturday AHA.  

Share
New Message
Please login to post a reply